Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder

References

• Gakis G, Efstathiou JA, Lerner SP, Cookson MS, Keegan KA, Guru KA, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2012;63:45–57.
   PubMed Web of Science ®Google Scholar
• Gakis G, Witjes JA, Comperat E, Cowan NC, De Santis M, Lebret T, et al. EAU guidelines on primary urethral carcinoma. Eur Urol 2013;64:823–30.
   PubMed Web of Science ®Google Scholar
• Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 2003;169:96–100; discussion 100.
   PubMed Web of Science ®Google Scholar
• Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997;158:62–7.
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666–75.
   PubMed Web of Science ®Google Scholar
• Stein JP, Penson DF. Invasive T1 bladder cancer: indications and rationale for radical cystectomy. BJU Int 2008;102:270–5.
   PubMed Web of Science ®Google Scholar
• Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O´Donnell MA, et al. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 2009;103:475–9.
   PubMed Web of Science ®Google Scholar
• Manoharan M, Katkoori D, Kishore TA, Jorda M, Luongo T, Soloways MS. Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? World J Urol 2010;28:233–7.
   PubMed Web of Science ®Google Scholar
• O’Donnell RK, Feldman M, Mick R, Muschel RJ. Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion. J Histochem Cytochem 2008;56:803–10.
   PubMed Web of Science ®Google Scholar
• Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59:997–1008.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Wittekind C. TNM classification of malignant tumours. Bladder cancer. 6th edition. Oxford: Wiley-Blackwell; 2002:199–202.
   Google Scholar
• Solsona E, Iborra I, Rubio J, Casanova J, Almenar S. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. BJU Int 2004;94:1258–62.
   PubMed Web of Science ®Google Scholar
• Masood S, Sriprasad S, Palmer JH, Mufti GR. T1G3 bladder cancer - indications for early cystectomy. Int Urol Nephrol 2004;36:41–4.
   PubMed Web of Science ®Google Scholar
• Cheng L, Neumann RM, Scherer BG, Weaver AL, Leibovich BC, Nehra A, et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 1999;85:2638–47.
   PubMed Web of Science ®Google Scholar
• Marinho VF, Metze K, Sanches FS, Rocha GF, Gobbi H. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis. BMC Cancer 2008;8:64.
   PubMed Web of Science ®Google Scholar
• Evangelou E, Kyzas PA, Trikalinos TA. Comparison of diagnostic accuracy of lymphatic endothelium markers: a Bayesian approach. Mod Pathol 2005;18:1490–7.
   PubMed Web of Science ®Google Scholar
• Cho KS, Seo HK, Joung JY, Park W, Ro JY, Han KS, et al. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. J Urol 2009;182:2625–30.
   PubMed Web of Science ®Google Scholar
• Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. J Urol 2003;169:2110–12.
   PubMed Web of Science ®Google Scholar
• Kuroda H, Nakai M, Ohnisi K, Ishida T, Kuroda M, Itoyama S. Vascular invasion in triple-negative carcinoma of the breast identified by endothelial lymphatic and blood vessel markers. Int J Surg Pathol 2010;18:324–9.
   PubMed Web of Science ®Google Scholar
• Dicken BJ, Graham K, Hamilton SM, Andrews S, Lai R, Listgarten J, et al. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 2006;243:64–73.
   PubMed Web of Science ®Google Scholar
• Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. Guidelines on testicular cancer. Eur Urol 2011;60:304–19.
   PubMed Web of Science ®Google Scholar
• Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 2007;20:183–91.
   PubMed Web of Science ®Google Scholar
• Yiou R, Patard JJ, Benhard H, Abbou CC, Chopin DK. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 2002;89:374–8.
   PubMed Web of Science ®Google Scholar
• Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994;73:1926–31.
   PubMed Web of Science ®Google Scholar
• Orsola A, Trias I, Raventos CX, Espanol I, Cecchini L, Bucar S, et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005;48:231–8; discussion 238.
   PubMed Web of Science ®Google Scholar
• Cheng L, Weaver AL, Neumann RM, Scherer BG, Bostwick DG. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal. Cancer 1999;86:1035–43.
   PubMed Web of Science ®Google Scholar
• Kondylis FI, Demirci S, Ladaga L, Kolm P, Schellhammer PF. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma. J Urol 2000;163:1120–3.
   PubMed Web of Science ®Google Scholar
• Paner GP, Shen SS, Lapetino S, Venkataraman G, Barkan GA, Quek ML, et al. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2009;33:91–8.
   PubMed Web of Science ®Google Scholar